These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 31505066)

  • 1. Mechanisms of Dupilumab.
    Harb H; Chatila TA
    Clin Exp Allergy; 2020 Jan; 50(1):5-14. PubMed ID: 31505066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupilumab: Mechanism of action, clinical, and translational science.
    McCann MR; Kosloski MP; Xu C; Davis JD; Kamal MA
    Clin Transl Sci; 2024 Aug; 17(8):e13899. PubMed ID: 39080841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctivitis in dupilumab clinical trials.
    Akinlade B; Guttman-Yassky E; de Bruin-Weller M; Simpson EL; Blauvelt A; Cork MJ; Prens E; Asbell P; Akpek E; Corren J; Bachert C; Hirano I; Weyne J; Korotzer A; Chen Z; Hultsch T; Zhu X; Davis JD; Mannent L; Hamilton JD; Teper A; Staudinger H; Rizova E; Pirozzi G; Graham NMH; Shumel B; Ardeleanu M; Wollenberg A
    Br J Dermatol; 2019 Sep; 181(3):459-473. PubMed ID: 30851191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global influence of dupilumab on Quality of Life in a severe asthma patient with T2 multimorbidities: a case report on atopic dermatitis, chronic rhinosinusitis with nasal polyposis, and eosinophilic esophagitis.
    Colque-Bayona M; Hernández-Cano N; Tomás-Pérez M; Caballero T; Quirce S; Domínguez-Ortega J
    J Asthma; 2024 Jul; 61(7):762-765. PubMed ID: 38152869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
    Kariyawasam HH
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
    [No Abstract]   [Full Text] [Related]  

  • 6. Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents.
    Licari A; Castagnoli R; Marseglia A; Olivero F; Votto M; Ciprandi G; Marseglia GL
    Paediatr Drugs; 2020 Jun; 22(3):295-310. PubMed ID: 32157553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.
    Humbert M; Bousquet J; Bachert C; Palomares O; Pfister P; Kottakis I; Jaumont X; Thomsen SF; Papadopoulos NG
    J Allergy Clin Immunol Pract; 2019; 7(5):1418-1429. PubMed ID: 30928481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    Benzecry V; Pravettoni V; Segatto G; Marzano AV; Ferrucci S
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):261-263. PubMed ID: 32732182
    [No Abstract]   [Full Text] [Related]  

  • 9. Dupilumab: Basic aspects and applications to allergic diseases.
    Matsunaga K; Katoh N; Fujieda S; Izuhara K; Oishi K
    Allergol Int; 2020 Apr; 69(2):187-196. PubMed ID: 32007360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis.
    Eschenbacher W; Straesser M; Knoeddler A; Li RC; Borish L
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):539-547. PubMed ID: 33012318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commonality of the IL-4/IL-13 pathway in atopic diseases.
    Gandhi NA; Pirozzi G; Graham NMH
    Expert Rev Clin Immunol; 2017 May; 13(5):425-437. PubMed ID: 28277826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice.
    Tauber M; Apoil PA; Richet C; Laurent J; De Bonnecaze G; Mouchon E; Cassagne M; Marguery MC; Hegazy S; Konstantinou MP; Severino M; Uthurriague C; Giordano-Labadie F; Didier A; Paul C
    Br J Dermatol; 2019 Jun; 180(6):1551-1552. PubMed ID: 30633329
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
    Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
    van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab for the treatment of adolescents with atopic dermatitis.
    Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
    Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dupilumab in the treatment of eosinophilic esophagitis.
    Syverson EP; Rubinstein E; Lee JJ; McDonald DR; Hait E
    Immunotherapy; 2024; 16(13):845-852. PubMed ID: 39073081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab for the treatment of asthma.
    Pelaia C; Vatrella A; Gallelli L; Terracciano R; Navalesi P; Maselli R; Pelaia G
    Expert Opin Biol Ther; 2017 Dec; 17(12):1565-1572. PubMed ID: 28990423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated reappraisal of dupilumab in children and adolescents with moderate-severe atopic dermatitis.
    Ciprandi G; Licari A; Tosca MA; Miraglia Del Giudice M; Belloni Fortina A; Marseglia GL
    Pediatr Allergy Immunol; 2024 Jun; 35(6):e14181. PubMed ID: 38934228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders.
    Hait EJ; McDonald DR
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):213-225. PubMed ID: 30206783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to "allergic inflammation".
    Nakayama T
    Immunol Rev; 2017 Jul; 278(1):5-7. PubMed ID: 28658548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.